<scp>IGF2BP2</scp> promotes pancreatic carcinoma progression by enhancing the stability of <scp>B3GNT6 mRNA</scp> via <scp>m6A</scp> methylation

Pei Cao, Yufan Wu, Ding Sun, Weigang Zhang, Junyi Qiu, Zuxiong Tang, Xiaofeng Xue, Lei Qin

Cancer Medicine · 2022 · 23 citations · 40 references

DOIFull text

Open access

Abstract

Elevated m6A levels promote PC progression. IGF2BP2 is a credible marker and modulates B3GNT6 mRNA stability, indicating that IGF2BP2 is a potential prognostic marker and therapeutic target in PC progression.

References

40